, Nat Rev DisPrimers, vol.23, p.17013, 2017.
Clinical features of LRRK2 carriers with Parkinson's disease, Advances in Neurobiology, vol.14, pp.31-48 ,
LRRK2 G2019S in the North African popu-lation: a review, Eur Neurol, vol.63, issue.6, pp.321-325, 2010. ,
Genetic movement disorders in patients of Jewish ancestry, JAMA Neurol, vol.71, issue.12, pp.1567-1572, 2014. ,
MDS clinical diagnostic criteria for Parkinson's disease, Mov Disord, vol.30, issue.12, pp.1591-1601, 2015. ,
Systematic review of levodopa dose equivalency reporting in Parkinson's disease, Mov Disord, vol.25, issue.15, pp.2649-2653, 2010. ,
The unified Parkinson's disease rating scale, RecentDevelopments in Parkinson's Disease, vol.1987, pp.153-163 ,
Parkinsonism: onset progression and mortality, Neurology, vol.17, issue.5, pp.427-442, 1967. ,
Mini--Mental State" A practical method for grading the cognitive state of patients for the clinician, J Psychiatr Res, vol.12, issue.3, pp.189-198, 1975. ,
Effect of education on the mini--mental state examination as a screening test for dementia, J Am Geriatr Soc, vol.39, issue.9, pp.876-880, 1991. ,
Comparison of Beck depression inventories--IA and --II in psychiatric outpatients, J Pers Assess, vol.67, issue.3, pp.588-597, 1996. ,
Assessment of depression in medical patients: a systematic review of the utility of the Beck depression inventory--II, Clinics (Sao Paulo), vol.68, issue.9, pp.1274-1287, 2013. ,
Variable expression of Parkinson's disease: a base--line analysis of the DATATOP cohort. The Parkinson study group, Neurology, vol.40, issue.10, pp.1529-1534, 1990. ,
Sex differences in LRRK2 G2019S and idiopathic Parkinson's disease, Ann Clin Transl Neurol, vol.4, issue.11, pp.801-810, 2017. ,
Age--specific penetrance of LRRK2 G2019S in the Michael J. Fox Ashkenazi Jewish LRRK2 con-sortium, Neurology, vol.85, issue.1, pp.89-95, 2015. ,
Motor progression of Parkinson's disease with the leucine--rich repeat kinase 2 G2019S mutation, Mov Disord, vol.29, issue.8, pp.1057-1060, 2014. ,
Phenotype, genotype, and worldwide genetic penetrance of LRRK2--associated Parkinson's disease: a case--control study, Lancet Neurol, vol.7, issue.7, pp.583-590, 2008. ,
A comparative study of LRRK2, PINK1 and genetically undefined familial Parkinson's dis-ease, J Neurol Neurosurg Psychiatry, vol.81, issue.4, pp.391-395, 2010. ,
Phenotype in parkinsonian and nonparkinsonian LRRK2 G2019S mutation carriers, Neurology, vol.77, issue.4, pp.325-333, 2011. ,
Parkinson disease phenotype in Ashkenazi Jews with and without LRRK2 G2019S mutations, Mov Disord, vol.28, issue.14, pp.1966-1971, 2013. ,
A comparative study of Parkinson's disease and leucine--rich repeat kinase 2 p. G2019S par-kinsonism, Neurobiol Aging, vol.35, issue.5, pp.1125-1131, 2014. ,
LRRK2 G2019S mutation: prevalence and clinical features in moroccans with Parkinson's dis-ease, Parkinsons Dis, p.2412486, 2017. ,
Screening for Lrrk2 G2019S and clinical comparison of Tunisian and North American Caucasian Parkinson's disease families, Mov Disord, vol.22, issue.1, pp.55-61, 2007. ,
Motor and non--motor heterogeneity of LRRK2--related and idiopathic Parkinson's disease, Mov Disord, vol.31, issue.8, pp.1192-1202, 2016. ,
Fall risk and gait in Parkinson's disease: the role of the LRRK2 G2019S mutation, MovDisord, vol.28, issue.12, pp.1683-1690, 2013. ,
Neuropsychological performance in LRRK2 G2019S carriers with Parkinson's disease, Parkinsonism Relat Disord, vol.21, pp.106-110, 2015. ,
Progression in the LRRK2--associated Parkinson disease population, JAMA Neurol, vol.75, issue.3, pp.312-319, 2018. ,
Motor phenotype of LRRK2--associated Parkinson's disease: a Tunisian longitudinal study, MovDisord, vol.30, issue.2, pp.253-258, 2015. ,
Cognitive and be-havioral symptoms in Parkinson's disease patients with the G2019S and R1441G mutations of the LRRK2 gene, Parkinsonism RelatDisord, vol.21, issue.5, pp.494-499, 2015. ,
Cognitive profile of LRRK2--related Parkinson's disease, Mov Disord, vol.30, issue.5, pp.728-733, 2015. ,
Cognitive dysfunction in Tunisian LRRK2 associated Parkinson's disease, Parkinsonism RelatDisord, vol.18, issue.3, pp.243-246, 2012. ,
Using KASP technique to screen LRRK2 G2019S mutation in a large Tunisian cohort, BMC Med Genet, vol.18, issue.1, p.70, 2017. ,
URL : https://hal.archives-ouvertes.fr/pasteur-01639043
The LRRK2 G2019S mu-tation in Ashkenazi Jews with Parkinson disease: is there a gender effect?, Neurology, vol.69, issue.16, pp.1595-1602, 2007. ,
LRRK2 mutations in Parkinson's disease: confirmation of a gender effect in the Italian population, Parkinsonism Relat Disord, vol.20, issue.8, pp.911-914, 2014. ,
LRRK2 mutations in Parkinson disease; a sex effect or lack thereof? A meta--analysisParkinsonism Relat Disord, vol.21, pp.778-782, 2015. ,
Gender differences in Parkinson's disease: a clinical perspective, Acta Neurol Scand, vol.136, issue.6, pp.570-584, 2017. ,
Clinical features of Parkinson disease patients with homozygous leucine--rich repeat kinase 2 G2019S mutations, Arch Neurol, vol.63, issue.9, pp.1250-1254, 2006. ,
URL : https://hal.archives-ouvertes.fr/hal-00221455
How to cite this article ,
, LRRK2 G2019S Parkinson's disease with more benign phenotype than idiopathic
, Acta Neurol Scand, vol.00, pp.1-7, 2018.
,
Phosphoinositides in cell regulation and membrane dynamics, Nature, vol.443, pp.651-657, 2006. ,
,
Homozygous nonsense mutation in SYNJ1 associated with intractable epilepsy and tau pathology, Neurobiol Aging, vol.36, pp.1222-1223, 2015. ,
Synaptojanin 1: localization on coated endocytic intermediates in nerve terminals and interaction of its 170 kDa isoform with Eps15, FEBS Lett, vol.419, pp.1451-1459, 1997. ,
Loss of SYNJ1 dual phosphatase activity leads to early onset refractory seizures and progressive neurological decline, EuroEPINOMICS RES Consortium, vol.139, pp.2420-2430, 2016. ,
The genetics and neuropathology of Parkinson's disease, Acta Neuropathol (Berl), vol.124, pp.325-338, 2012. ,
Identification of a novel homozygous mutation Arg459Pro in SYNJ1 gene of an Indian family with autosomal recessive juvenile Parkinsonism, Parkinsonism Relat Disord, vol.31, pp.124-128, 2016. ,
,
Phosphoinositide-metabolizing enzymes at the interface between membrane traffic and cell signalling, EMBO Rep, vol.8, pp.241-246, 2007. ,
The Sac1 domain of SYNJ1 identified mutated in a family with early-onset progressive Parkinsonism with generalized seizures, Hum Mutat, vol.34, pp.1200-1207, 2013. ,
The dual phosphatase activity of synaptojanin1 is required for both efficient synaptic vesicle endocytosis and reavailability at nerve terminals, Neuron, vol.56, pp.1004-1018, 2007. ,
Clinical approach to Parkinson's disease: features, diagnosis, and principles of management. Cold Spring Harb Perspect Med 2:a008870, 2012. ,
A presynaptic inositol-5-phosphatase, Nature, vol.379, pp.353-357, 1996. ,
Endocytic accessory proteins are functionally distinguished by their differential effects on the maturation of clathrin-coated pits, Mol Biol Cell, vol.20, pp.3251-3260, 2009. ,
PARK20 caused by SYNJ1 homozygous Arg258Gln mutation in a new Italian family, Neurogenetics, vol.15, pp.183-188, 2014. ,
Two synaptojanin 1 isoforms are recruited to clathrin-coated pits at different stages, Proc Natl Acad Sci U S A, vol.103, pp.19332-19337, 2006. ,
Clinical progression of SYNJ1-related early onset atypical parkinsonism: 3-year follow up of the original Italian family, J Neurol, vol.261, pp.823-824, 2014. ,
Evolving nature of the AP2 ?-appendage hub during clathrin, 2004. ,
, Monogenic Parkinson's disease and parkinsonism: clinical phenotypes and frequencies of known mutations, Parkinsonism Relat Disord, vol.23, pp.407-415, 2013.
New genes causing hereditary Parkinson's disease or parkinsonism, Curr Neurol Neurosci Rep, vol.17, p.66, 2017. ,
Mutation in the SYNJ1 gene associated with autosomal recessive, early-onset Parkinsonism, Hum Mutat, vol.34, pp.1208-1215, 2013. ,
Gene-environment interactions in Parkinson's disease, Parkinsonism Relat Disord, vol.13, issue.3, pp.309-315, 2007. ,
Role of the AP2 ?appendage hub in recruiting partners for clathrin, 2006. ,
, PLoS Biol, vol.4, p.262
Role of dynamin, synaptojanin, and endophilin in podocyte foot processes, J Clin Invest, vol.122, pp.4401-4411, 2012. ,
A clinical and molecular genetic study of 50 families with autosomal recessive parkinsonism revealed known and novel gene mutations, Mol Neurobiol, vol.55, pp.3477-3489, 2018. ,
Specificity determinants in phosphoinositide dephosphorylation: crystal struc-ture of an archetypal inositol polyphosphate 5-phosphatase, Cell, vol.105, pp.379-389, 2001. ,
An essay on the shaking palsy. 1817, J Neuropsychiatry Clin Neurosci, vol.14, pp.223-236, 2002. ,
Bourneville b 1840 (1884) Leçons sur les maladies du système nerveux faites à la salpêtrière, A. Delahaye 3. Charcot J-M (1987) Charcot, the Clinician: The Tuesday Lessons: Excerpts from Nine Case Presentations on General Neurology Delivered at the Salpetriere Hospital in 1887-88 ,
How common are the "common" neurologic disorders, Neurology, vol.68, pp.326-337, 2007. ,
The prevalence of Parkinson's disease: A systematic review and meta-analysis, Mov Disord, vol.29, pp.1583-1590, 2014. ,
The Incidence of Parkinson's Disease: A Systematic Review and Meta-Analysis, NED, vol.46, pp.292-300, 2016. ,
Parkinson's Disease: From Pathogenesis to Pharmacogenomics, Int J Mol Sci, vol.18, 2017. ,
Heterogeneity in male to female risk for Parkinson's disease, J Neurol Neurosurg Psychiatry, vol.78, pp.905-906, 2007. ,
Are men at greater risk for Parkinson's disease than women?, J Neurol Neurosurg Psychiatry, vol.75, pp.637-639, 2004. ,
Parkinson disease male-to-female ratios increase with age: French nationwide study and meta-analysis, J Neurol Neurosurg Psychiatry, vol.87, pp.952-957, 2016. ,
Hysterectomy, menopause, and estrogen use preceding Parkinson's disease: an exploratory case-control study, Mov Disord, vol.16, pp.830-837, 2001. ,
Increased risk of parkinsonism in women who underwent oophorectomy before menopause, Neuro, vol.70, pp.200-209, 2008. ,
Parkinson's Disease in the Gulf Countries: An Updated Review, ENE, vol.74, pp.222-225, 2015. ,
Parkinson's disease in Africa: A systematic review of epidemiologic and genetic studies, Movement Disorders, vol.21, pp.2150-2156, 2006. ,
The prevalence and genetics of Parkinson's disease in sub-Saharan Africans, Journal of the Neurological Sciences, vol.335, pp.22-25, 2013. ,
Prevalence study of neurologic disorders in Kelibia (Tunisia), Neuroepidemiology, vol.12, pp.285-299, 1993. ,
Comparing clinical features of young onset, middle onset and late onset Parkinson's disease, Parkinsonism & Related Disorders, vol.20, pp.530-534, 2014. ,
La maladie de Parkinson, 2e édition, 2011. ,
Parkinson's disease: clinical features and diagnosis, J Neurol Neurosurg Psychiatry, vol.79, pp.368-376, 2008. ,
, Gowers W (1893) A manual of diseases of the nervous system
Hypokinesia without decrement distinguishes progressive supranuclear palsy from Parkinson's disease, Brain, vol.135, pp.1141-1153, 2012. ,
Predictors of falls and fractures in bradykinetic rigid syndromes: a retrospective study, J Neurol Neurosurg Psychiatry, vol.77, pp.468-473, 2006. ,
Predictors of freezing in Parkinson's disease: a survey of 6,620 patients, Mov Disord, vol.22, pp.953-956, 2007. ,
Non-motor symptoms in Parkinson's disease, Parkinsonism Relat Disord, vol.22, pp.119-122, 2016. ,
The clinical symptoms of Parkinson's disease, J Neurochem, vol.139, pp.318-324, 2016. ,
Non-motor features of Parkinson disease, Nature Reviews Neuroscience, vol.18, p.435, 2017. ,
Prediagnostic presentations of Parkinson's disease in primary care: a case-control study, Lancet Neurol, vol.14, pp.57-64, 2015. ,
Research on the Premotor Symptoms of Parkinson's Disease: Clinical and Etiological Implications, Environmental Health Perspectives, vol.121, p.1245, 2013. ,
Autonomic dysfunctions in idiopathic Parkinson's disease, J Neurol, vol.250, pp.28-30, 2003. ,
EFNS guidelines on the diagnosis and management of orthostatic hypotension, Eur J Neurol, vol.13, pp.930-936, 2006. ,
Anal sphincter dysfunction in Parkinson's disease, Arch Neurol, vol.46, pp.1061-1064, 1989. ,
Parkinson disease: the enteric nervous system spills its guts, Neurology, vol.77, pp.1761-1767, 2011. ,
Gastrointestinal dysfunction in Parkinson's Disease, J Neurol Sci, vol.289, pp.69-73, 2010. ,
Frequency of bowel movements and the future risk of Parkinson's disease, Neurology, vol.57, pp.456-462, 2001. ,
Lower urinary tract dysfunction in patients with parkinsonism and other neurodegenerative disorders, Handb Clin Neurol, vol.130, pp.335-356, 2015. ,
Voiding dysfunction and Parkinson's disease: urodynamic abnormalities and urinary symptoms, J Urol, vol.164, pp.1640-1643, 2000. ,
Sweating dysfunctions in Parkinson's disease, J Neurol, vol.253, pp.42-47, 2006. ,
Skin function and skin disorders in Parkinson's disease, J Neural Transm, vol.108, pp.205-213, 2001. ,
Hyposialorrhea as an early manifestation of Parkinson disease, Auton Neurosci, vol.150, pp.150-151, 2009. ,
Autonomic disorders predicting Parkinson disease, Parkinsonism Relat Disord, vol.20, pp.94-98, 2014. ,
Sleep disorders associated with Parkinson's disease: role of dopamine, epidemiology, and clinical scales of assessment, CNS Spectr, vol.13, pp.6-11, 2008. ,
Waking up to sleep episodes in Parkinson's disease, Mov Disord, vol.15, pp.212-215, 2000. ,
Sleep disorders in patients with Parkinson's disease: epidemiology and management, CNS Drugs, vol.15, pp.267-275, 2001. ,
Sleep matters in Parkinson's disease: use of a priority list to assess the presence of sleep disturbances, Eur J Neurol, vol.20, pp.259-265, 2013. ,
Sleep disorders and daytime sleepiness in Parkinson's disease, Curr Neurol Neurosci Rep, vol.9, pp.173-180, 2009. ,
Excessive daytime sleepiness in patients with Parkinson's disease, CNS Drugs, vol.25, pp.203-212, 2011. ,
Cognitive impairment in early-stage non-demented Parkinson's disease patients, Acta Neurologica Scandinavica, vol.129, pp.307-318, 2014. ,
Cognitive Impairment in Parkinson's Disease: The Dual Syndrome Hypothesis, Neurodegener Dis, vol.11, pp.79-92, 2012. ,
Dopaminergic modulation of cortical function in patients with Parkinson's disease, Ann Neurol, vol.51, pp.156-164, 2002. ,
Prevalence and characteristics of dementia in Parkinson disease: an 8-year prospective study, Arch Neurol, vol.60, pp.387-392, 2003. ,
Neuropathologic substrates of Parkinson's disease dementia, Ann Neurol, vol.72, pp.587-598, 2012. ,
Changes in motor subtype and risk for incident dementia in Parkinson's disease, Mov Disord, vol.21, pp.1123-1130, 2006. ,
Association of Olfactory Bulb Volume and Olfactory Sulcus Depth with Olfactory Function in Patients with Parkinson Disease, American Journal of Neuroradiology, vol.32, pp.677-681, 2011. ,
Visual symptoms in Parkinson's disease and Parkinson's disease dementia, Mov Disord, vol.26, pp.2387-2395, 2011. ,
Dopamine agonists in the treatment of early Parkinson's disease: A meta-analysis, Parkinsonism & Related Disorders, vol.15, pp.287-294, 2009. ,
Hallucinations in Parkinson's disease: prevalence, phenomenology and risk factors, Brain, vol.123, pp.733-745, 2000. ,
Visual hallucinations in Parkinson's disease: theoretical models, Mov Disord, vol.29, pp.1591-1598, 2014. ,
Visual exploration in Parkinson's disease and Parkinson's disease dementia, Brain, vol.136, pp.739-750, 2013. ,
Pain in Parkinson's disease: Prevalence and characteristics, PAIN®, vol.141, pp.173-177, 2009. ,
Depression in Parkinson's disease, Ideggyogy Sz, vol.67, pp.229-236, 2014. ,
Mood disorders in Parkinson's disease, Parkinsonism & Related Disorders, vol.18, issue.11, pp.70024-70028, 2012. ,
Depression in Parkinson's Disease: The Contribution from Animal Studies, Parkinsons Dis, 2017. ,
Beyond the iron mask: towards better recognition and treatment of depression associated with Parkinson's disease, Mov Disord, vol.17, pp.445-454, 2002. ,
Risk of Parkinson's disease following anxiety disorders: a nationwide population-based cohort study, Eur J Neurol, vol.22, pp.1280-1287, 2015. ,
Movement Disorder Societysponsored revision of the Unified Parkinson's Disease Rating Scale (MDS-UPDRS): scale presentation and clinimetric testing results, Mov Disord, vol.23, pp.2129-2170, 2008. ,
MDS clinical diagnostic criteria for Parkinson's disease, Mov Disord, vol.30, pp.1591-1601, 2015. ,
The Unified Parkinson's Disease Rating Scale, Recent Developments in Parkinson's Disease, pp.153-163, 1987. ,
Movement Disorder Societysponsored revision of the Unified Parkinson's Disease Rating Scale (MDS-UPDRS): Process, format, and clinimetric testing plan, Mov Disord, vol.22, pp.41-47, 2007. ,
Parkinsonism: onset, progression and mortality, Neurology, vol.17, pp.427-442, 1967. ,
Postoperative medical evaluation of 26 selected patients with Parkinson's disease, J Am Geriatr Soc, vol.4, pp.1219-1232, 1956. ,
ECDEU assessment manual for psychopharmacology, Rev. 1976. U.S. Dept. of Health, Education, and Welfare, Public Health Service, Alcohol, Drug Abuse, and Mental Health Administration, 1976. ,
A practical method for grading the cognitive state of patients for the clinician, J Psychiatr Res, vol.12, pp.189-198, 1975. ,
Population-based norms for the Mini-Mental State Examination by age and educational level, JAMA, vol.269, pp.2386-2391, 1993. ,
MoCA: a brief screening tool for mild cognitive impairment, The Montreal Cognitive Assessment, vol.53, pp.695-699, 2005. ,
The FAB: a Frontal Assessment Battery at bedside, Neurology, vol.55, pp.1621-1626, 2000. ,
Development and validation of a geriatric depression screening scale: a preliminary report, J Psychiatr Res, vol.17, pp.37-49, 1982. ,
Comparison of Beck Depression Inventories -IA and -II in psychiatric outpatients, J Pers Assess, vol.67, pp.588-597, 1996. ,
The MOS 36-item short-form health survey, 1992. ,
Conceptual framework and item selection, Med Care, vol.30, pp.473-483 ,
The development and validation of a short measure of functioning and well being for individuals with Parkinson's disease, Qual Life Res, vol.4, pp.241-248, 1995. ,
Anatomie cérébrale. Les noyaux gris centraux et la région mesencephalo-sous-optique ; suivi d'une appendice sur l'anatomie pathologique de la maladie de Parkinson, 1925. ,
Morphological taxonomy of the neurons of the primate striatum, J Comp Neurol, vol.313, pp.273-294, 1991. ,
GABA as the pallidothalamic neurotransmitter: implications for basal ganglia function, Brain Res, vol.207, pp.195-199, 1981. ,
Terminals of subthalamonigral fibres are enriched with glutamate-like immunoreactivity: an electron microscopic, immunogold analysis in the cat, J Chem Neuroanat, vol.6, pp.19-30, 1993. ,
Parallel organization of functionally segregated circuits linking basal ganglia and cortex, Annu Rev Neurosci, vol.9, pp.357-381, 1986. ,
The functional anatomy of basal ganglia disorders, Trends Neurosci, vol.12, pp.366-375, 1989. ,
Basal ganglia-thalamocortical circuits: parallel substrates for motor, oculomotor, "prefrontal" and "limbic" functions, Prog Brain Res, vol.85, pp.119-146, 1990. ,
Maladie de Parkinson idiopathique : aspects cliniques, diagnostiques et thérapeutiques, Encycl Med Chir Elsevier SAS, 2001. ,
Re-evaluation of the functional anatomy of the basal ganglia in normal and Parkinsonian states, Neuroscience, vol.76, pp.335-343, 1997. ,
Neuropathology of Parkinson disease, Parkinsonism & Related Disorders, vol.46, pp.30-33, 2018. ,
Localization of monoamines in the lower brain stem, Experientia, vol.20, pp.398-399, 1964. ,
Distribution of noradrenaline and dopamine (3-hydroxytyramine) in the human brain and their behavior in diseases of the extrapyramidal system, 1960. ,
, Klin Wochenschr, vol.38, pp.1236-1239
Biochemical aspects of Parkinson's disease, Neurology, vol.51, pp.2-9, 1998. ,
Midbrain dopaminergic cell loss in Parkinson's disease: computer visualization, Ann Neurol, vol.26, pp.507-514, 1989. ,
The substantia nigra of the human brain. II. Patterns of loss of dopamine-containing neurons in Parkinson's disease, Brain, vol.122, pp.1437-1448, 1999. ,
Clinical progression in Parkinson disease and the neurobiology of axons, Ann Neurol, vol.67, pp.715-725, 2010. ,
Contributions a l'etude de l'anatomie pathologique du locus niger de soemmering avec quelques deductions relatives a la pathogenie des troubles de tonus musculaire et de la maladie de Parkinson, 1919. ,
Neuronal loss is greater in the locus coeruleus than nucleus basalis and substantia nigra in Alzheimer and Parkinson diseases, Arch Neurol, vol.60, pp.337-341, 2003. ,
Age-related loss of dorsal vagal neurons in Parkinson's disease, Neurology, vol.42, pp.2106-2111, 1992. ,
Neuronal loss in the pedunculopontine tegmental nucleus in Parkinson disease and in progressive supranuclear palsy, Proc Natl Acad Sci, vol.84, pp.5976-5980, 1987. ,
Pathology of Parkinson's disease. Changes other than the nigrostriatal pathway, Mol Chem Neuropathol, vol.14, pp.153-197, 1991. ,
Autonomic involvement in Parkinson's disease: pathology, pathophysiology, clinical features and possible peripheral biomarkers, J Neurol Sci, vol.313, pp.57-63, 2012. ,
Axonal alpha-synuclein aggregates herald centripetal degeneration of cardiac sympathetic nerve in Parkinson's disease, Brain, vol.131, pp.642-650, 2008. ,
The anterior olfactory nucleus in Parkinson's disease, Mov Disord, vol.10, pp.283-287, 1995. ,
A stable proportion of Lewy body bearing neurons in the substantia nigra suggests a model in which the Lewy body causes neuronal death, Neurobiol Aging, vol.31, pp.99-103, 2010. ,
Neuropathological substrates of Alzheimer's disease and Parkinson's disease, J Neural Transm Suppl, vol.24, pp.109-129, 1987. ,
, lewy FH (1912) Paralysis agitans. 1. Pathologische Anatomie, pp.920-933
Alpha-synuclein in Lewy bodies, Nature, vol.388, pp.839-840, 1997. ,
Validation of the Neuropathologic Criteria of the Third Consortium for Dementia with Lewy Bodies for Prospectively Diagnosed Cases, J Neuropathol Exp Neurol, vol.67, pp.649-656, 2008. ,
Beneficial effects of nicotine, cotinine and its metabolites as potential agents for Parkinson's disease, Front Aging Neurosci, vol.6, 2015. ,
Gene-environment interactions in Parkinson's disease, Parkinsonism Relat Disord, vol.13, issue.08, pp.70022-70023, 2007. ,
The epidemiology of Parkinson's disease: risk factors and prevention, The Lancet Neurology, vol.15, pp.1257-1272, 2016. ,
Parkinson's disease: Evidence for environmental risk factors, Mov Disord, vol.28, pp.8-13, 2013. ,
Chronic Parkinsonism in humans due to a product of meperidine-analog synthesis, Science, vol.219, pp.979-980, 1983. ,
Subcutaneous rotenone exposure causes highly selective dopaminergic degeneration and alpha-synuclein aggregation, Exp Neurol, vol.179, pp.9-16, 2003. ,
Occupation and risk of parkinsonism: a multicenter case-control study, Arch Neurol, vol.66, pp.1106-1113, 2009. ,
,
Rotenone, paraquat, and Parkinson's disease, Environ Health Perspect, vol.119, pp.866-872, 2011. ,
Parkinson's Disease and Residential Exposure to Maneb and Paraquat From Agricultural Applications in the Central Valley of California, Am J Epidemiol, vol.169, pp.919-926, 2009. ,
, , 2015.
, Methamphetamine/amphetamine abuse and risk of Parkinson's disease in Utah: A population-based assessment, Drug and Alcohol Dependence, vol.146, pp.30-38
Methamphetamineinduced deficits of brain monoaminergic neuronal markers: distal axotomy or neuronal plasticity, Neuroscience, vol.122, pp.499-513, 2003. ,
Head injury and Parkinson's disease risk in twins, Ann Neurol, vol.60, pp.65-72, 2006. ,
Systematic Review of the Risk of Parkinson's Disease After Mild Traumatic Brain Injury: Results of the International Collaboration on Mild Traumatic Brain Injury Prognosis, Archives of Physical Medicine and Rehabilitation, vol.95, pp.238-244, 2014. ,
A metaanalysis of coffee drinking, cigarette smoking, and the risk of Parkinson's disease, 2002. ,
, Ann Neurol, vol.52, pp.276-284
Caffeine protects against combined paraquat and maneb-induced dopaminergic neuron degeneration, Experimental Neurology, vol.223, pp.657-661, 2010. ,
Neuroprotection by caffeine: time course and role of its metabolites in the MPTP model of Parkinson's disease, Neuroscience, vol.167, pp.475-481, 2010. ,
Caffeine in Parkinson's disease: Comment on its importance and the dose proposal, Mov Disord, vol.27, pp.808-808, 2012. ,
Caffeine for treatment of Parkinson disease, Neurology, vol.79, pp.651-658, 2012. ,
Plasma urate and risk of Parkinson's disease, Am J Epidemiol, vol.166, pp.561-567, 2007. ,
Serum urate as a predictor of clinical and radiographic progression in Parkinson disease, Arch Neurol, vol.65, pp.716-723, 2008. ,
Intakes of vitamins E and C, carotenoids, vitamin supplements, and PD risk, Neurology, vol.59, pp.1161-1169, 2002. ,
Parkinson's disease in twins, J Neurol Neurosurg Psychiatry, vol.50, pp.105-106, 1987. ,
Parkinson's disease in a nationwide twin cohort, Neurology, vol.38, pp.1217-1219, 1988. ,
Parkinson's disease in 65 pairs of twins and in a set of quadruplets, Neurology, vol.33, pp.815-824, 1983. ,
Twin studies and the genetics of Parkinson's disease--a reappraisal, Mov Disord, vol.5, pp.187-194, 1990. ,
Parkinson disease in twins: an etiologic study, JAMA, vol.281, pp.341-346, 1999. ,
A clinical genetic study of Parkinson's disease: evidence for dominant transmission, Neurology, vol.44, pp.499-506, 1994. ,
Mapping of a Gene for Parkinson's Disease to Chromosome 4q21-q23, Science, vol.274, pp.1197-1199, 1996. ,
Mutation in the ?-Synuclein Gene Identified in Families with Parkinson's Disease, Science, vol.276, pp.2045-2047, 1997. ,
The genetics and neuropathology of Parkinson's disease, Acta Neuropathol, vol.124, pp.325-338, 2012. ,
Monogenic Parkinson's disease and parkinsonism: clinical phenotypes and frequencies of known mutations, Parkinsonism Relat Disord, vol.19, pp.407-415, 2013. ,
New Genes Causing Hereditary Parkinson's Disease or Parkinsonism, Curr Neurol Neurosci Rep, vol.17, p.66, 2017. ,
The genetics of Parkinson disease, Ageing Research Reviews, vol.42, pp.72-85, 2018. ,
Frequency of known mutations in early onset PD; implication for genetic counseling: the CORE-PD study, Arch Neurol, vol.67, pp.1116-1122, 2010. ,
Systematic Review and UK-Based Study of PARK2 (parkin), PINK1, PARK7 (DJ-1) and LRRK2 in early-onset Parkinson's disease, Mov Disord, vol.27, pp.1522-1529, 2012. ,
Parkinson's disease: from monogenic forms to genetic susceptibility factors, Hum Mol Genet, vol.18, pp.48-59, 2009. ,
Parkinson disease: insights in clinical, genetic and pathological features of monogenic disease subtypes, J Chem Neuroanat, vol.42, pp.131-141, 2011. ,
Human and Mouse ?-Synuclein Genes: Comparative Genomic Sequence Analysis and Identification of a Novel Gene Regulatory Element, Genome Res, vol.11, pp.78-86, 2001. ,
Identification of two distinct synucleins from human brain, FEBS Lett, vol.345, pp.27-32, 1994. ,
) ?-Synuclein produces a long-lasting increase in neurotransmitter release, The EMBO Journal, vol.23, pp.4506-4516, 2004. ,
Mice Lacking ?-Synuclein Display Functional Deficits in the Nigrostriatal Dopamine System, Neuron, vol.25, pp.239-252, 2000. ,
Direct Membrane Association Drives Mitochondrial Fission by the Parkinson Disease-associated Protein ?-Synuclein, J Biol Chem, vol.286, pp.20710-20726, 2011. ,
) ?-Synuclein Blocks ER-Golgi Traffic and Rab1 Rescues Neuron Loss in Parkinson's Models, Science, vol.313, pp.324-328, 2006. ,
Expression of A53T Mutant But Not Wild-Type ?-Synuclein in PC12 Cells Induces Alterations of the Ubiquitin-Dependent Degradation System, Loss of Dopamine Release, and Autophagic Cell Death, J Neurosci, vol.21, pp.9549-9560, 2001. ,
AlaSOPro mutation in the gene encoding ?-synuclein in Parkinson's disease, Nature Genetics, vol.18, pp.106-108, 1998. ,
The new mutation, E46K, of ?synuclein causes parkinson and Lewy body dementia, Ann Neurol, vol.55, pp.164-173, 2004. ,
) ?-Synuclein Gene Rearrangements in Dominantly Inherited Parkinsonism: Frequency, Phenotype, and Mechanisms, Arch Neurol, vol.66, pp.102-108, 2009. ,
Mutations in LRRK2 Cause Autosomal-Dominant Parkinsonism with Pleomorphic Pathology, Neuron, vol.44, pp.601-607, 2004. ,
Cloning of the Gene Containing Mutations that Cause PARK8-Linked Parkinson's Disease, Neuron, vol.44, pp.595-600, 2004. ,
Roc, a Ras/GTPase domain in complex proteins, Biochimica et Biophysica Acta (BBA) -Molecular Cell Research, vol.1643, pp.5-10, 2003. ,
The Familial Parkinsonism Gene LRRK2 Regulates Neurite Process Morphology, Neuron, vol.52, pp.587-593, 2006. ,
LRRK2 controls synaptic vesicle storage and mobilization within the recycling pool, J Neurosci, vol.31, pp.2225-2237, 2011. ,
LRK-1, a C. elegans PARK8-related kinase, regulates axonal-dendritic polarity of SV proteins, Curr Biol, vol.17, pp.592-598, 2007. ,
LRRK2 regulates synaptic vesicle endocytosis, Exp Cell Res, vol.314, pp.2055-2065, 2008. ,
Leucine-rich repeat kinase 2 (LRRK2) interacts with parkin, and mutant LRRK2 induces neuronal degeneration, PNAS, vol.102, pp.18676-18681, 2005. ,
Lrrk2 phosphorylates alpha synuclein at serine 129: Parkinson disease implications, Biochem Biophys Res Commun, vol.387, pp.149-152, 2009. ,
LRRK2, a puzzling protein: insights into Parkinson's disease pathogenesis, Exp Neurol, vol.0, pp.206-216, 2014. ,
A new locus for Parkinson's disease (PARK8) maps to chromosome 12p11.2-q13, Ann Neurol, vol.1, pp.296-301, 2002. ,
, Arch Neurol, vol.67, pp.542-547, 2010.
Lrrk2 R1441G-related Parkinson's disease: evidence of a common founding event in the seventh century in Northern Spain, Neurogenetics, vol.10, p.347, 2009. ,
LRRK2 G2019S as a Cause of Parkinson's Disease in North African Arabs, New England Journal of Medicine, vol.354, pp.422-423, 2006. ,
URL : https://hal.archives-ouvertes.fr/hal-00221453
The LRRK2 G2019S mutation in Ashkenazi Jews with Parkinson disease: is there a gender effect, Neurology, vol.69, pp.1595-1602, 2007. ,
Parkinson's disease-related LRRK2 G2019S mutation results from independent mutational events in humans, Hum Mol Genet, vol.19, 1998. ,
URL : https://hal.archives-ouvertes.fr/inserm-00522011
Motor phenotype of LRRK2 G2019S carriers in early-onset Parkinson disease, Arch Neurol, vol.66, pp.1517-1522, 2009. ,
Motor phenotype of LRRK2-associated Parkinson's disease: a Tunisian longitudinal study, Mov Disord, vol.30, pp.253-258, 2015. ,
A comparative study of LRRK2, PINK1 and genetically undefined familial Parkinson's disease, J Neurol Neurosurg Psychiatry, vol.81, pp.391-395, 2010. ,
Cloning and Characterization of Human VPS35 and Mouse Vps35 and Mapping of VPS35 to Human Chromosome 16q13-q21, Genomics, vol.70, pp.253-257, 2000. ,
Human Homologues of Yeast Vacuolar Protein Sorting 29 and 35, Biochemical and Biophysical Research Communications, vol.277, pp.622-630, 2000. ,
VPS35 Mutations in Parkinson Disease, The American Journal of Human Genetics, vol.89, pp.162-167, 2011. ,
A Mutation in VPS35, Encoding a Subunit of the Retromer Complex, Causes Late-Onset Parkinson Disease, The American Journal of Human Genetics, vol.89, pp.168-175, 2011. ,
VPS35 mutation in Japanese patients with typical Parkinson's disease, Mov Disord, vol.27, pp.1413-1417, 2012. ,
Identification of VPS35 mutations replicated in French families with Parkinson disease, Neurology, vol.78, pp.1449-1450, 2012. ,
URL : https://hal.archives-ouvertes.fr/inserm-00807463
Frequency of the D620N Mutation in VPS35 in Parkinson Disease, Arch Neurol, vol.69, pp.1360-1364, 2012. ,
The human glucocerebrosidase gene and pseudogene: Structure and evolution, Genomics, vol.4, pp.87-96, 1989. ,
Gaucher disease: new molecular approaches to diagnosis and treatment, Science, vol.256, pp.794-799, 1992. ,
X-ray structure of human acid-?glucosidase, the defective enzyme in Gaucher disease, EMBO Rep, vol.4, pp.704-709, 2003. ,
Glucosylceramide lipidosis-Gaucher disease, The Metabolic and Molecular Bases of Inherited Disease. Scriver, pp.3635-3668, 2001. ,
A mutation in the human glucocerebrosidase gene in neuronopathic Gaucher's disease, N Engl J Med, vol.316, pp.570-575, 1987. ,
Neurological manifestations in patients with Gaucher disease and their relatives, it is just a coincidence?, J Inherit Metab Dis, vol.34, pp.781-787, 2011. ,
Increased incidence of Parkinson disease among relatives of patients with Gaucher disease, Molecules, and Diseases, vol.36, pp.426-428, 2006. ,
Occurrence of Parkinson's syndrome in type I Gaucher disease, QJM, vol.89, pp.691-694, 1996. ,
Gaucher disease with parkinsonian manifestations: does glucocerebrosidase deficiency contribute to a vulnerability to parkinsonism?, Molecular Genetics and Metabolism, vol.79, pp.104-109, 2003. ,
The Spectrum of Parkinsonian Manifestations Associated With Glucocerebrosidase Mutations, Arch Neurol, vol.65, pp.1353-1357, 2008. ,
Large-scale screening of the Gaucher's disease-related glucocerebrosidase gene in Europeans with Parkinson's disease, Hum Mol Genet, vol.20, pp.202-210, 2011. ,
Mutations in GBA are associated with familial Parkinson disease susceptibility and age at onset, Neurology, vol.72, pp.310-316, 2009. ,
The role of glucocerebrosidase in Parkinson disease pathogenesis, FEBS J Epub ahead of print, 2018. ,
GBA Variants Influence Motor and Non-Motor Features of Parkinson's Disease, PLoS ONE, vol.11, p.167749, 2016. ,
GBA-Associated Parkinson's Disease: Progression in a Deep Brain Stimulation Cohort, J Parkinsons Dis, vol.7, pp.635-644, 2017. ,
The clinical features of Parkinson's disease in patients with mutations and polymorphic variants of GBA gene, 2017. ,
, Zh Nevrol Psikhiatr Im S S Korsakova, vol.117, pp.81-86
Glucocerebrosidase mutations influence the natural history of Parkinson's disease in a community-based incident cohort, Brain, vol.136, pp.392-399, 2013. ,
The parkinsonian phenotype of spinocerebellar ataxia type 3 in a Taiwanese family, Parkinsonism Relat Disord, vol.10, pp.369-373, 2004. ,
Intrafamilial variability of Parkinson phenotype in SCAs: novel cases due to SCA2 and SCA3 expansions, Parkinsonism Relat Disord, vol.15, pp.374-378, 2009. ,
Are interrupted SCA2 CAG repeat expansions responsible for parkinsonism, Neurology, vol.69, pp.1970-1975, 2007. ,
URL : https://hal.archives-ouvertes.fr/hal-00221466
The sepiapterin reductase gene region reveals association in the PARK3 locus: analysis of familial and sporadic Parkinson's disease in European populations, J Med Genet, vol.43, pp.557-562, 2006. ,
Role of sepiapterin reductase gene at the PARK3 locus in Parkinson's disease, Neurobiol Aging, vol.32, 2011. ,
The ubiquitin pathway in Parkinson's disease, Nature, vol.395, pp.451-452, 1998. ,
Mutations in the GIGYF2 (TNRC15) Gene at the PARK11 Locus in Familial Parkinson Disease, The American Journal of Human Genetics, vol.82, pp.822-833, 2008. ,
URL : https://hal.archives-ouvertes.fr/hal-00280725
GIGYF2 variants are not associated with Parkinson's disease in Italy, Mov Disord, vol.24, pp.1867-1868, 2009. ,
GIGYF2 mutations are not a frequent cause of familial Parkinson's disease, Parkinsonism & Related Disorders, vol.15, pp.703-705, 2009. ,
Variation in GIGYF2 is not associated with Parkinson disease, Neurology, vol.72, pp.1886-1892, 2009. ,
Loss of function mutations in the gene encoding Omi/HtrA2 in Parkinson's disease, Hum Mol Genet, vol.14, pp.2099-2111, 2005. ,
A large-scale genetic association study to evaluate the contribution of Omi/HtrA2 (PARK13) to Parkinson's disease, Neurobiol Aging, vol.32, pp.548-557, 2011. ,
Genetic variation of Omi/HtrA2 and Parkinson's disease, Parkinsonism & Related Disorders, vol.14, pp.539-543, 2008. ,
Genetic variability in the mitochondrial serine protease HTRA2 contributes to risk for Parkinson disease, Hum Mutat, vol.29, pp.832-840, 2008. ,
A new mutation in the GCH1 gene presents as early-onset Parkinsonism, Parkinsonism & Related Disorders, vol.15, pp.160-161, 2009. ,
Mutations in progranulin cause tau-negative frontotemporal dementia linked to chromosome 17, Nature, vol.442, pp.916-919, 2006. ,
Prominent phenotypic variability associated with mutations in Progranulin, Neurobiology of Aging, vol.30, pp.739-751, 2009. ,
Broadening the phenotype of <Emphasis Type="Italic">TARDBP</Emphasis> mutations: the <Emphasis Type="Italic">TARDBP</Emphasis> Ala382Thr mutation and Parkinson's disease in Sardinia, Neurogenetics, vol.12, pp.203-209, 2011. ,
Association of missense and 5?-splicesite mutations in tau with the inherited dementia FTDP-17, Nature, vol.393, pp.702-705, 1998. ,
Frontotemporal dementia and parkinsonism linked to chromosome 17 -the first Polish family, European Journal of Neurology, vol.18, pp.535-537, 2011. ,
Hereditary Frontotemporal Dementia Caused by Tau Gene Mutations, Brain Pathology, vol.17, pp.63-73, 2007. ,
Early-onset familial parkinsonism due to POLG mutations, Ann Neurol, vol.59, pp.859-862, 2006. ,
Mutation of the Linker Region of the Polymerase ?-1 (POLG1Gene Associated With Progressive External Ophthalmoplegia and Parkinsonism, Arch Neurol, vol.64, pp.553-557, 2007. ,
Parkinsonism associated with the homozygous W748S mutation in the POLG1 gene, Parkinsonism & Related Disorders, vol.14, pp.652-654, 2008. ,
Translation Initiator EIF4G1 Mutations in Familial Parkinson Disease, The American Journal of Human Genetics, vol.89, pp.398-406, 2011. ,
The Genomic Structure and Promoter Region of the Human Parkin Gene, Biochemical and Biophysical Research Communications, vol.286, pp.863-868, 2001. ,
Parkin Mediates Proteasomedependent Protein Degradation and Rupture of the Outer Mitochondrial Membrane, J Biol Chem, vol.286, pp.19630-19640, 2011. ,
Parkin uses the UPS to ship off dysfunctional mitochondria, Autophagy, vol.7, pp.771-772, 2011. ,
Mutations in the parkin gene cause autosomal recessive juvenile parkinsonism, Nature, vol.392, pp.605-608, 1998. ,
Association between early-onset Parkinson's disease and mutations in the parkin gene, N Engl J Med, vol.342, pp.1560-1567, 2000. ,
RING finger 1 mutations in Parkin produce altered localization of the protein, Hum Mol Genet, vol.12, pp.2957-2965, 2003. ,
The C289G and C418R missense mutations cause rapid sequestration of human Parkin into insoluble aggregates, Neurobiol Dis, vol.14, pp.357-364, 2003. ,
Alterations in the solubility and intracellular localization of parkin by several familial Parkinson's disease-linked point mutations, J Neurochem, vol.93, pp.422-431, 2005. ,
Mitochondrial dysfunction and oxidative damage in parkin-deficient mice, J Biol Chem, vol.279, pp.18614-18622, 2004. ,
How much phenotypic variation can be attributed to parkin genotype, Ann Neurol, vol.54, pp.176-185, 2003. ,
Localization of a Novel Locus for Autosomal Recessive Early-Onset Parkinsonism, PARK6, on Human Chromosome 1p35-p36, Am J Hum Genet, vol.68, pp.895-900, 2001. ,
Hereditary Early-Onset Parkinson's Disease Caused by Mutations in PINK1, Science, vol.304, pp.1158-1160, 2004. ,
The PINK1/Parkin pathway regulates mitochondrial morphology, PNAS, vol.105, pp.1638-1643, 2008. ,
The ubiquitin kinase PINK1 recruits autophagy receptors to induce mitophagy, Nature, vol.524, pp.309-314, 2015. ,
The Roles of PINK1, Parkin and Mitochondrial Fidelity in Parkinson's Disease, Neuron, vol.85, pp.257-273, 2015. ,
Loss-of-Function of Human PINK1 Results in Mitochondrial Pathology and Can Be Rescued by Parkin, J Neurosci, vol.27, pp.12413-12418, 2007. ,
Mitochondrial localization of the Parkinson's disease related protein DJ-1: implications for pathogenesis, Hum Mol Genet, vol.14, pp.2063-2073, 2005. ,
DJ-1 has a role in antioxidative stress to prevent cell death, EMBO Rep, vol.5, pp.213-218, 2004. ,
The Parkinson's disease protein DJ-1 is neuroprotective due to cysteine-sulfinic acid-driven mitochondrial localization, Proc Natl Acad Sci U S A, vol.101, pp.9103-9108, 2004. ,
Mutations in the DJ-1 gene associated with autosomal recessive early-onset parkinsonism, Science, vol.299, pp.256-259, 2003. ,
DJ-1 mutations and parkinsonismdementia-amyotrophic lateral sclerosis complex, Ann Neurol, vol.58, pp.803-807, 2005. ,
Hereditary parkinsonism with dementia is caused by mutations in ATP13A2, encoding a lysosomal type 5 P-type ATPase, Nat Genet, vol.38, pp.1184-1191, 2006. ,
Kufor Rakeb disease: autosomal recessive, levodopa-responsive parkinsonism with pyramidal degeneration, supranuclear gaze palsy, and dementia, Mov Disord, vol.20, pp.1264-1271, 2005. ,
Characterization of PLA2G6 as a locus for dystonia-parkinsonism, Annals of Neurology, vol.65, pp.19-23, 2009. ,
Genome-wide Linkage Analysis of a Parkinsonian-Pyramidal Syndrome Pedigree by 500 K SNP Arrays, Am J Hum Genet, vol.82, pp.1375-1384, 2008. ,
A Deleterious Mutation in DNAJC6 Encoding the Neuronal-Specific Clathrin-Uncoating Co-Chaperone Auxilin, Is Associated with Juvenile Parkinsonism. PLOS ONE, vol.7, p.36458, 2012. ,
DNAJC6 is responsible for juvenile parkinsonism with phenotypic variability, Parkinsonism & Related Disorders, vol.19, pp.320-324, 2013. ,
, DNAJC6 Mutations Associated With Early-Onset Parkinson's Disease, vol.79, pp.244-256, 2016.
The Sac1 domain of SYNJ1 identified mutated in a family with early-onset progressive Parkinsonism with generalized seizures, Hum Mutat, vol.34, pp.1200-1207, 2013. ,
Mutation in the SYNJ1 gene associated with autosomal recessive, early-onset Parkinsonism, Hum Mutat, vol.34, pp.1208-1215, 2013. ,
Loss of SYNJ1 dual phosphatase activity leads to early onset refractory seizures and progressive neurological decline, Brain, vol.139, pp.2420-2430, 2016. ,
Novel mutations in SPG11 cause hereditary spastic paraplegia associated with early-onset levodopa-responsive Parkinsonism, Movement Disorders, vol.26, pp.553-556, 2011. ,
Loss of VPS13C Function in Autosomal-Recessive Parkinsonism Causes Mitochondrial Dysfunction and Increases PINK1/Parkin-Dependent Mitophagy, Am J Hum Genet, vol.98, pp.500-513, 2016. ,
URL : https://hal.archives-ouvertes.fr/hal-01289266
SPG11 spastic paraplegia. A new cause of juvenile parkinsonism, J Neurol, vol.256, pp.104-108, 2009. ,
URL : https://hal.archives-ouvertes.fr/inserm-00370093
,
Mitochondrial dynamics, cell death and the pathogenesis of Parkinson's disease, Apoptosis, vol.15, pp.1336-1353, 2010. ,
The centrality of mitochondria in the pathogenesis and treatment of Parkinson's disease, CNS Neurosci Ther, vol.20, pp.591-602, 2014. ,
Unravelling mitochondrial pathways to Parkinson's disease, Br J Pharmacol, vol.171, pp.1943-1957, 2014. ,
The impact of reactive oxygen species and genetic mitochondrial mutations in Parkinson's disease, Gene, vol.532, pp.18-23, 2013. ,
Parkinson disease: from pathology to molecular disease mechanisms, Free Radic Biol Med, vol.62, pp.132-144, 2013. ,
Advances in the genetics of Parkinson disease, Nat Rev Neurol, vol.9, pp.445-454, 2013. ,
Aromatic amino acids and modification of parkinsonism, N Engl J Med, vol.276, pp.374-379, 1967. ,
Sixteen-year follow-up of 100 patients begun on levodopa in 1968: emerging problems, Adv Neurol, vol.45, pp.469-472, 1987. ,
, Entre Bourguiba et Hannibal: identité tunisienne et histoire depuis l'indépendance. Karthala, 2005.
Bulletins et Mémoires de la Société d'anthropologie de Paris, 1915. ,
Genetic variation in Tunisia in the context of human diversity worldwide, American Journal of Physical Anthropology, vol.161, p.62, 2016. ,
Genetic structure of Tunisian ethnic groups revealed by paternal lineages, Am J Phys Anthropol, vol.146, pp.271-280, 2011. ,
Langue et littérature berbères, vol.3, 2004. ,
Functional coherence of the human Y chromosome, Science, vol.278, pp.675-680, 1997. ,
Y chromosome sequence variation and the history of human populations, Nat Genet, vol.26, pp.358-361, 2000. ,
The phylogeography of Y chromosome binary haplotypes and the origins of modern human populations, 2001. ,
, Ann Hum Genet, vol.65, pp.43-62
New binary polymorphisms reshape and increase resolution of the human Y chromosomal haplogroup tree, 2008. ,
, Genome Res, vol.18, pp.830-838
A Revised Root for the Human Y Chromosomal Phylogenetic Tree: The Origin of Patrilineal Diversity in Africa, The American Journal of Human Genetics, vol.88, pp.814-818, 2011. ,
Global distribution of Y-chromosome haplogroup C reveals the prehistoric migration routes of African exodus and early settlement in East Asia, Journal of Human Genetics, vol.55, pp.428-435, 2010. ,
Excavating Y-chromosome haplotype strata in Anatolia, Hum Genet, vol.114, pp.127-148, 2004. ,
Phylogeography of Y-chromosome haplogroup I reveals distinct domains of prehistoric gene flow in europe, Am J Hum Genet, vol.75, pp.128-137, 2004. ,
Origin, diffusion, and differentiation of Y-chromosome haplogroups E and J: inferences on the neolithization of Europe and later migratory events in the Mediterranean area, Am J Hum Genet, vol.74, pp.1023-1034, 2004. ,
Unexpected NRY chromosome variation in Northern Island Melanesia, Mol Biol Evol, vol.23, pp.1628-1641, 2006. ,
High-resolution SNPs and microsatellite haplotypes point to a single, recent entry of Native American Y chromosomes into the Americas, Mol Biol Evol, vol.21, pp.164-175, 2004. ,
, , 2013.
, Accessed, vol.3, 2018.
Genetic diversity in Tunisia: a study based on the GM polymorphism of human immunoglobulins, Hum Biol, vol.76, pp.559-567, 2004. ,
A study of Gm allotypes and immunoglobulin heavy gamma IGHG genes in Berbers, Arabs and sub-Saharan Africans from Jerba Island, European Journal of Immunogenetics, vol.28, pp.531-538, 2001. ,
HLA class II genetic diversity in southern Tunisia and the Mediterranean area, International Journal of Immunogenetics, vol.33, pp.93-103, 2006. ,
Polymorphism of HLA class II genes in Berbers from Southern Tunisia, Tissue Antigens, vol.76, pp.416-420, 2010. ,
STR data for 21 loci in northwestern Africa, Forensic Science International, vol.116, pp.41-51, 2001. ,
Substructure of a Tunisian Berber Population as Inferred from 15 Autosomal Short Tandem Repeat Loci, Human Biology, vol.80, pp.435-448, 2008. ,
Alu polymorphisms in Jerba Island population (Tunisia): comparative study in Arab and Berber groups, 2006. ,
, Ann Hum Biol, vol.33, pp.634-640
Assessing human genetic diversity in Tunisian Berber populations by Alu insertion polymorphisms, Ann Hum Biol, vol.38, pp.53-58, 2011. ,
Distribution of Y chromosome lineages in Jerba island population, Forensic Sci Int, vol.148, pp.211-218, 2005. ,
Y-chromosome markers distribution in Northern Africa: High-resolution SNP and STR analysis in Tunisia and Morocco populations, Forensic Science International: Genetics Supplement Series, vol.1, pp.235-236, 2008. ,
Effect of education on the mini-mental state examination as a screening test for dementia, J Am Geriatr Soc, vol.39, pp.876-880, 1991. ,
Assessment of depression in medical patients: A systematic review of the utility of the Beck Depression Inventory-II, Clinics (Sao Paulo), vol.68, pp.1274-1287, 2013. ,
Systematic review of levodopa dose equivalency reporting in Parkinson's disease, Mov Disord, vol.25, pp.2649-2653, 2010. ,
Variable expression of Parkinson's disease: a base-line analysis of the DATATOP cohort. The Parkinson Study Group, Neurology, vol.40, pp.1529-1534, 1990. ,
ConSurf 2010: calculating evolutionary conservation in sequence and structure of proteins and nucleic acids, Nucleic Acids Res, vol.38, pp.529-533, 2010. ,
Computational approaches for predicting the biological effect of p53 missense mutations: a comparison of three sequence analysis based methods, Nucleic Acids Res, vol.34, pp.1317-1325, 2006. ,
PROVEAN web server: a tool to predict the functional effect of amino acid substitutions and indels, Bioinformatics, vol.31, pp.2745-2747, 2015. ,
Predicting functional effect of human missense mutations using PolyPhen-2, Curr Protoc Hum Genet Chapter, p.20, 2013. ,
Characterization of diseaseassociated single amino acid polymorphisms in terms of sequence and structure properties, J Mol Biol, vol.315, pp.771-786, 2002. ,
Predicting the insurgence of human genetic diseases associated to single point protein mutations with support vector machines and evolutionary information, Bioinformatics, vol.22, pp.2729-2734, 2006. ,
Functional annotations improve the predictive score of human disease-related mutations in proteins, Hum Mutat, vol.30, pp.1237-1244, 2009. ,
MutationTaster2: mutation prediction for the deep-sequencing age, Nat Methods, vol.11, pp.361-362, 2014. ,
Automated inference of molecular mechanisms of disease from amino acid substitutions, Bioinformatics, vol.25, pp.2744-2750, 2009. ,
I-Mutant2.0: predicting stability changes upon mutation from the protein sequence or structure, Nucleic Acids Res, vol.33, pp.306-310, 2005. ,
Relative quantification of 40 nucleic acid sequences by multiplex ligation-dependent probe amplification, Nucleic Acids Res, vol.30, p.57, 2002. ,
Genotyping Multiallelic Copy Number Variation with Multiplex Ligation-Dependent Probe Amplification (MLPA), Methods Mol Biol, vol.1492, pp.147-153, 2017. ,
DNM3 and genetic modifiers of age of onset in LRRK2 Gly2019Ser parkinsonism: a genome-wide linkage and association study, The Lancet Neurology, vol.15, pp.1248-1256, 2016. ,
Kinetic PCR analysis: real-time monitoring of DNA amplification reactions, Biotechnology (NY), vol.11, pp.1026-1030, 1993. ,
La PCR en temps réel: principes et applications, Reviews in Biology and Biotechnology, vol.2, pp.2-11, 2002. ,
Real-time quantitative PCR analysis of mitochondrial DNA content, Curr Protoc Hum Genet Chapter, 2011. ,
Quantitative Evaluation of the Mitochondrial DNA Depletion Syndrome, Clinical Chemistry, vol.56, pp.1119-1127, 2010. ,
Parkinson's disease-associated mutations in leucine-rich repeat kinase 2 augment kinase activity, Proc Natl Acad Sci U S A, vol.102, pp.16842-16847, 2005. ,
LRRK2 phosphorylates moesin at threonine-558: characterization of how Parkinson's disease mutants affect kinase activity, Biochem J, vol.405, pp.307-317, 2007. ,
URL : https://hal.archives-ouvertes.fr/hal-00478755
G2019S LRRK2 mutation in French and North African families with Parkinson's disease, Annals of Neurology, vol.58, pp.784-787, 2005. ,
Using KASP technique to screen LRRK2 G2019S mutation in a large Tunisian cohort, BMC Med Genet, vol.18, 2017. ,
URL : https://hal.archives-ouvertes.fr/pasteur-01639043
A frequent LRRK2 gene mutation associated with autosomal dominant Parkinson's disease, Lancet, vol.365, pp.412-415, 2005. ,
Genetic screening for a single common LRRK2 mutation in familial Parkinson's disease, The Lancet, vol.365, pp.410-412, 2005. ,
A common LRRK2 mutation in idiopathic Parkinson's disease, Lancet, vol.365, pp.415-416, 2005. ,
LRRK2 G2019S mutation does not contribute to Parkinson's disease in South India, Neurology India, vol.59, p.157, 2011. ,
Variable frequency of LRRK2 variants in the Latin American research consortium on the genetics of Parkinson's disease (LARGE-PD), a case of ancestry, NPJ Parkinsons Dis, vol.3, 2017. ,
The LRRK2 G2019S mutation as the cause of Parkinson's disease in Ashkenazi Jews, J Neural Transm, vol.116, pp.1473-1482, 2009. ,
LRRK2 G2019S as a cause of Parkinson's disease in Ashkenazi Jews, N Engl J Med, vol.354, pp.424-425, 2006. ,
Phenotype, genotype, and worldwide genetic penetrance of LRRK2-associated Parkinson's disease: a casecontrol study, The Lancet Neurology, vol.7, pp.583-590, 2008. ,
Genetic screening of the G2019S mutation of the LRRK2 gene in Southwest European, North African, and Sephardic Jewish subjects, Genet Test, vol.12, pp.333-339, 2008. ,
A founding LRRK2 haplotype shared by Tunisian, US, European and Middle Eastern families with Parkinson's disease, Parkinsonism & Related Disorders, vol.14, pp.77-80, 2008. ,
The G6055A (G2019S) mutation in LRRK2 is frequent in both early and late onset Parkinson's disease and originates from a common ancestor, J Med Genet, vol.42, p.65, 2005. ,
Identification of a Novel LRRK2 Mutation Linked to Autosomal Dominant Parkinsonism: Evidence of a Common Founder across European Populations, Am J Hum Genet, vol.76, pp.672-680, 2005. ,
LRRK2 Haplotype Analyses in European and North African Families with Parkinson Disease: A Common Founder for the G2019S Mutation Dating from the 13th Century, Am J Hum Genet, vol.77, pp.330-332, 2005. ,
LRRK2 G2019S in Families with Parkinson Disease Who Originated from Europe and the Middle East: Evidence of Two Distinct Founding Events Beginning Two Millennia Ago, Am J Hum Genet, vol.79, pp.752-758, 2006. ,
Identification and haplotype analysis of LRRK2 G2019S in Japanese patients with Parkinson disease, Neurology, vol.67, pp.697-699, 2006. ,
Clinicogenetic study of mutations in LRRK2 exon 41 in Parkinson's disease patients from 18 countries, Mov Disord, vol.21, pp.1102-1108, 2006. ,
Ashkenazi Parkinson's disease patients with the LRRK2 G2019S mutation share a common founder dating from the second to fifth centuries, neurogenetics, vol.10, pp.355-358, 2009. ,
Evidence for prehistoric origins of the G2019S mutation in the North African Berber population, PLoS One, vol.12, 2017. ,
New contribution on the LRRK2 G2019S mutation associated to Parkinson's disease: age estimation of a common founder event of old age in Moroccan Berbers, International Journal of Modern Anthropology, vol.1, pp.11-22, 2012. ,
Parkinson's Disease in Saudi Patients: A Genetic Study, PLoS One, vol.10, 2015. ,
G2019S mutation of the leucine-rich repeat kinase 2 gene in a cohort of Egyptian patients with Parkinson's disease, Genet Test Mol Biomarkers, vol.15, pp.861-866, 2011. ,
Genetic Analysis of Leucin-Rich Repeat Kinase 2 (LRRK2) G2019S Mutation in a Sample of Egyptian Patients with Références Parkinson's Disease, a Pilot Study, British Journal of Medicine and Medical Research, vol.5, pp.404-408, 2015. ,
Phylogeographic Analysis of Haplogroup E3b (E-M215) Y Chromosomes Reveals Multiple Migratory Events Within and Out Of Africa, Am J Hum Genet, vol.74, pp.1014-1022, 2004. ,
Clinical Features of LRRK2 Carriers with Parkinson's Disease, Leucine-Rich Repeat Kinase 2 (LRRK2), pp.31-48, 2017. ,
Sex differences in LRRK2 G2019S and idiopathic Parkinson's Disease, Ann Clin Transl Neurol, vol.4, pp.801-810, 2017. ,
Age-specific penetrance of LRRK2 G2019S in the Michael J. Fox Ashkenazi Jewish LRRK2 Consortium, Neurology, vol.85, pp.89-95, 2015. ,
Motor progression of Parkinson's disease with the leucine-rich repeat kinase 2 G2019S mutation, Movement Disorders, vol.29, pp.1057-1060, 2014. ,
Phenotype, genotype, and worldwide genetic penetrance of LRRK2-associated Parkinson's disease: a casecontrol study, Lancet Neurol, vol.7, pp.583-590, 2008. ,
Phenotype in parkinsonian and nonparkinsonian LRRK2 G2019S mutation carriers, Neurology, vol.77, pp.325-333, 2011. ,
Parkinson Disease Phenotype in Ashkenazi Jews with and without LRRK2 G2019S mutations, Mov Disord, vol.28, 2013. ,
A comparative study of Parkinson's disease and leucine-rich repeat kinase 2 p.G2019S parkinsonism, Neurobiology of Aging, vol.35, pp.1125-1131, 2014. ,
LRRK2 G2019S Mutation: Prevalence and Clinical Features in Moroccans with Parkinson's Disease, Parkinsons Dis, 2017. ,
Screening for Lrrk2 G2019S and clinical comparison of Tunisian and North American Caucasian Parkinson's disease families, Movement Disorders, vol.22, pp.55-61, 2007. ,
Motor and nonmotor heterogeneity of LRRK2-related and idiopathic Parkinson's disease, Mov Disord, vol.31, pp.1192-1202, 2016. ,
Fall risk and gait in Parkinson's disease: The role of the LRRK2 G2019S mutation, Movement Disorders, vol.28, pp.1683-1690, 2013. ,
Neuropsychological performance in LRRK2 G2019S carriers with Parkinson's disease, Parkinsonism Relat Disord, vol.21, pp.106-110, 2015. ,
Progression in the LRRK2 -Associated Parkinson Disease Population, JAMA Neurology, vol.75, p.312, 2018. ,
Cognitive and behavioral symptoms in Parkinson's disease patients with the G2019S and R1441G mutations of the LRRK2 gene, Parkinsonism & Related Disorders, vol.21, pp.494-499, 2015. ,
Cognitive Profile of LRRK2-related Parkinson's Disease, Mov Disord, vol.30, pp.728-733, 2015. ,
Cognitive dysfunction in Tunisian LRRK2 associated Parkinson's disease, Parkinsonism & Related Disorders, vol.18, pp.243-246, 2012. ,
LRRK2 mutations in Parkinson's disease: Confirmation of a gender effect in the Italian population, Parkinsonism Relat Disord, vol.20, pp.911-914, 2014. ,
LRRK2 mutations in Parkinson disease; a sex effect or lack thereof? A meta-analysis, Parkinsonism & Related Disorders, vol.21, pp.778-782, 2015. ,
Gender differences in Parkinson's disease: A clinical perspective, Acta Neurol Scand, vol.136, pp.570-584, 2017. ,
Clinical Features of Parkinson Disease Patients With Homozygous Leucine-Rich Repeat Kinase 2 G2019S Mutations, Archives of Neurology, vol.63, p.1250, 2006. ,
URL : https://hal.archives-ouvertes.fr/hal-00221455
Dissecting dynamin's role in clathrin-mediated endocytosis, Biochem Soc Trans, vol.37, pp.1022-1026, 2009. ,
Functional interaction of Parkinson's disease-associated LRRK2 with members of the dynamin GTPase superfamily, Hum Mol Genet, vol.23, pp.2055-2077, 2014. ,
) ?-synuclein (SNCA) but not dynamin 3 (DNM3) influences age at onset of leucine-rich repeat kinase 2 (LRRK2) Parkinson's disease in Spain, Mov Disord, vol.33, pp.637-641, 2018. ,
Mutations in the Glucocerebrosidase Gene and Parkinson's Disease in Ashkenazi Jews, New England Journal of Medicine, vol.351, pp.1972-1977, 2004. ,
The glucocerebrosidase gene and Parkinson's disease in Ashkenazi Jews, N Engl J Med, vol.352, pp.728-731, 2005. ,
Expression and functional characterization of mutated glucocerebrosidase alleles causing Gaucher disease in Spanish patients, Blood Cells Mol Dis, vol.32, pp.218-225, 2004. ,
Expression of mutated glucocerebrosidase alleles in human cells, Hum Mol Genet, vol.6, pp.887-895, 1997. ,
In silico and functional studies of the regulation of the glucocerebrosidase gene, Mol Genet Metab, vol.99, pp.275-282, 2010. ,
In silico identification of genetic variants in glucocerebrosidase (GBA) gene involved in Gaucher's disease using multiple software tools, Front Genet, vol.5, p.148, 2014. ,
Analysis and classification of 304 mutant alleles in patients with type 1 and type 3 Gaucher disease, Am J Hum Genet, vol.66, pp.1777-1786, 2000. ,
Differential effects of severe vs mild GBA mutations on Parkinson disease, Neurology, vol.84, pp.880-887, 2015. ,
Parkinson's disease phenotype is influenced by the severity of the mutations in the GBA gene, Parkinsonism Relat Disord, 2018. ,
,
Molecular characterization of type 3 (neuronopathic) Gaucher disease in Thai patients, Molecules, and Diseases, vol.39, pp.348-352, 2007. ,
Relative contribution of simple mutations vs. copy number variations in five Parkinson disease genes in the Belgian population, Human Mutation, vol.30, pp.1054-1061 ,
LRRK2 exonic variants and susceptibility to Parkinson's disease, Lancet Neurol, vol.10, pp.898-908, 2011. ,
Comprehensive analysis of the LRRK2 gene in sixty families with Parkinson's disease, Eur J Hum Genet, vol.14, pp.322-331, 2006. ,
Molecular analyses of the LRRK2 gene in European and North African autosomal dominant Parkinson's disease, J Med Genet, vol.46, pp.458-464, 2009. ,
Comprehensive analysis of LRRK2 in publicly available Parkinson's disease cases and neurologically normal controls, Human Mutation, vol.29, pp.485-490 ,
LRRK2 gene in Parkinson disease: mutation analysis and case control association study, Neurology, vol.65, pp.696-700, 2005. ,
Resequencing analysis of five Mendelian genes and the top genes from genome-wide association studies in Parkinson's Disease, Molecular Neurodegeneration, vol.11, p.29, 2016. ,
Analysis of non-synonymous-coding variants of Parkinson's disease-related pathogenic and susceptibility genes in East Asian populations, Hum Mol Genet, vol.23, pp.3891-3897, 2014. ,
Parkin dosage mutations have greater pathogenicity in familial PD than simple sequence mutations, Neurology, vol.73, pp.279-286, 2009. ,
Homozygous partial genomic triplication of the parkin gene in early-onset parkinsonism, Neuroscience Letters, vol.380, pp.257-259, 2005. ,
The importance of gene dosage studies: mutational analysis of the parkin gene in early-onset parkinsonism, Hum Mol Genet, vol.10, pp.1649-1656, 2001. ,
Heterozygosity for a mutation in the parkin gene leads to later onset Parkinson disease, Neurology, vol.60, pp.796-801, 2003. ,
Mutation analysis of the parkin gene in Russian families with autosomal recessive juvenile parkinsonism, Mov Disord, vol.18, pp.914-919, 2003. ,
Detection of Parkin (PARK2) and DJ1 (PARK7) mutations in early-onset Parkinson disease: Parkin mutation frequency depends on ethnic origin of patients, Hum Mutat, vol.23, p.525, 2004. ,
Early-onset Parkinson's disease in a Chinese population: 99mTc-TRODAT-1 SPECT, Parkin gene analysis and clinical study, Parkinsonism Relat Disord, vol.11, pp.173-180, 2005. ,
Dopaminergic dysfunction in unrelated, asymptomatic carriers of a single parkin mutation, Neurology, vol.65, p.1843, 2005. ,
Parkin mutations in familial and sporadic Parkinson's disease among Indians, Parkinsonism Relat Disord, vol.12, pp.239-245, 2006. ,
Clinical features and gene analysis in Korean patients with early-onset Parkinson disease, Arch Neurol, vol.63, pp.1170-1174, 2006. ,
The dual phosphatase activity of synaptojanin1 is required for both efficient synaptic vesicle endocytosis and reavailability at nerve terminals, Neuron, vol.56, pp.1004-1018, 2007. ,
A presynaptic inositol-5-phosphatase, Nature, vol.379, pp.353-357, 1996. ,
Phosphoinositides in cell regulation and membrane dynamics, Nature, vol.443, pp.651-657, 2006. ,
Two synaptojanin 1 isoforms are recruited to clathrin-coated pits at different stages, Proc Natl Acad Sci, vol.103, pp.19332-19337, 2006. ,
Specificity determinants in phosphoinositide dephosphorylation: crystal structure of an archetypal inositol polyphosphate 5-phosphatase, Cell, vol.105, pp.379-389, 2001. ,
Role of dynamin, synaptojanin, and endophilin in podocyte foot processes, J Clin Invest, vol.122, pp.4401-4411, 2012. ,
Phosphoinositide-metabolizing enzymes at the interface between membrane traffic and cell signalling, EMBO reports, vol.8, pp.241-246, 2007. ,
Evolving nature of the AP2 ?-appendage hub during clathrin-coated vesicle endocytosis, The EMBO Journal, vol.23, pp.4371-4383, 2004. ,
Synaptojanin 1: localization on coated endocytic intermediates in nerve terminals and interaction of its 170 kDa isoform with Eps15, FEBS Letters, vol.419, pp.175-180, 1997. ,
Endocytic Accessory Proteins Are Functionally Distinguished by Their Differential Effects on the Maturation of Clathrin-coated Pits, Mol Biol Cell, vol.20, pp.3251-3260, 2009. ,
Role of the AP2 ?-Appendage Hub in Recruiting Partners for Clathrin-Coated Vesicle Assembly, PLoS Biol, vol.4, 2006. ,
PARK20 caused by SYNJ1 homozygous Arg258Gln mutation in a new Italian family, Neurogenetics, vol.15, pp.183-188, 2014. ,
Identification of a novel homozygous mutation Arg459Pro in SYNJ1 gene of an Indian family with autosomal recessive juvenile Parkinsonism, Parkinsonism Relat Disord, vol.31, pp.124-128, 2016. ,
Homozygous nonsense mutation in SYNJ1 associated with intractable epilepsy and tau pathology, Neurobiol Aging, vol.36, 2015. ,
A Clinical and Molecular Genetic Study of 50 Families with Autosomal Recessive Parkinsonism Revealed Known and Novel Gene Mutations, Mol Neurobiol, 2017. ,
Clinical progression of SYNJ1-related early onset atypical parkinsonism: 3-year follow up of the original Italian family, J Neurol, vol.261, pp.823-824, 2014. ,
mutations and parkinsonism, Neurology, vol.71, pp.896-902, 2008. ,
Early-onset parkinsonism associated with PINK1 mutations: frequency, genotypes, and phenotypes, Neurology, vol.65, pp.87-95, 2005. ,
PINK1 mutation in Taiwanese earlyonset parkinsonism : clinical, genetic, and dopamine transporter studies, J Neurol, vol.254, pp.1347-1355, 2007. ,
Genetics of Parkinson's Disease, International Review of Neurobiology, pp.197-231, 2017. ,
Genetic Forms of Parkinson's Disease, Semin Neurol, vol.37, pp.135-146, 2017. ,
Genotype-Phenotype Relations for the Parkinson's Disease Genes Parkin, PINK1, DJ1: MDSGene Systematic Review, Movement Disorders, vol.33, pp.730-741, 2018. ,
The Carbohydrate-Active EnZymes database (CAZy): an expert resource for Glycogenomics, Nucleic Acids Res, vol.37, pp.233-238, 2009. ,
Developmental Analysis of CNS Pathology in the Lysosomal Storage Disease >-Mannosidosis, J Neuropathol Exp Neurol, vol.66, p.11, 2007. ,
Swainsonine, a potent mannosidase inhibitor, elevates rat liver and brain lysosomal alpha-D-mannosidase, decreases Golgi alpha-D-mannosidase II, and increases the plasma levels of several acid hydrolases, Arch Biochem Biophys, vol.224, pp.594-600, 1983. ,
Effects of swainsonine on rat liver and kidney: biochemical and morphological studies, J Cell Biol, vol.101, pp.339-349, 1985. ,
Developmental Analysis of CNS Pathology in the Lysosomal Storage Disease ?-Mannosidosis, J Neuropathol Exp Neurol, vol.66, pp.687-697, 2007. ,
Growth of ectopic dendrites on cortical pyramidal neurons in neuronal storage diseases correlates with abnormal accumulation of GM2 ganglioside, J Neurochem, vol.62, pp.1852-1862, 1994. ,
Ectopic dendrites occur only on cortical pyramidal cells containing elevated GM2 ganglioside in alphamannosidosis, Proc Natl Acad Sci, vol.88, pp.11330-11334, 1991. ,
Hereditary neurovisceral mannosidosis associated with alpha-mannosidase deficiency in a family of Persian cats, Acta Neuropathol, vol.58, pp.64-68, 1982. ,
Histopathology, electrodiagnostic testing, and magnetic resonance imaging show significant peripheral and central nervous system myelin abnormalities in the cat model of alpha-mannosidosis, J Neuropathol Exp Neurol, vol.60, pp.817-828, 2001. ,
Integrated analysis of protein composition, tissue diversity, and gene regulation in mouse mitochondria, Cell, vol.115, pp.629-640, 2003. ,
The AAA+ ATPase ATAD3A Controls Mitochondrial Dynamics at the Interface of the Inner and Outer Membranes, Mol Cell Biol, vol.30, 1984. ,
URL : https://hal.archives-ouvertes.fr/hal-02459107
ATPase family AAA domain-containing 3A is a novel anti-apoptotic factor in lung adenocarcinoma cells, J Cell Sci, vol.123, pp.1171-1180, 2010. ,
C. elegans ATAD-3 Is Essential for Mitochondrial Activity and Development, PLOS ONE, vol.4, p.7644, 2009. ,
URL : https://hal.archives-ouvertes.fr/in2p3-00025853
Recurrent De Novo and Biallelic Variation of ATAD3A, Encoding a Mitochondrial Membrane Protein, Results in Distinct Neurological Syndromes, The American Journal of Human Genetics, vol.99, pp.831-845, 2016. ,
ATPase-deficient mitochondrial inner membrane protein ATAD3A disturbs mitochondrial dynamics in dominant hereditary spastic paraplegia, Hum Mol Genet, vol.26, pp.1432-1443, 2017. ,
Genetic causes of mitochondrial DNA depletion in humans, Biochim Biophys Acta, vol.1792, pp.1103-1108, 2009. ,
Insulin-degrading Enzyme Regulates Extracellular Levels of Amyloid ?-Protein by Degradation, J Biol Chem, vol.273, pp.32730-32738, 1998. ,
Neurons regulate extracellular levels of amyloid beta-protein via proteolysis by insulin-degrading enzyme, J Neurosci, vol.20, pp.1657-1665, 2000. ,
Molecular bases for the recognition of short peptide substrates and cysteine-directed modifications of human insulin-degrading enzyme, Biochemistry, vol.47, pp.12822-12834, 2008. ,
Amyloid-? peptide levels in brain are inversely correlated with insulysin activity levels in vivo, PNAS, vol.100, pp.6221-6226, 2003. ,
Enhanced Proteolysis of ?-Amyloid in APP Transgenic Mice Prevents Plaque Formation, Secondary Pathology, and Premature Death, Neuron, vol.40, pp.1087-1093, 2003. ,
Insulin-degrading enzyme regulates the levels of insulin, amyloid -protein, and the -amyloid precursor protein intracellular domain in vivo, Proceedings of the National Academy of Sciences, vol.100, pp.4162-4167, 2003. ,
Functional Roles of Amyloid-? Protein Precursor and Amyloid-? Peptides: Evidence from Experimental Studies, Journal of Alzheimer's Disease, vol.18, pp.401-412, 2009. ,
Role of the beta-amyloid protein in Alzheimer's disease, FASEB J, vol.9, pp.366-370, 1995. ,
The Alzheimer's A beta peptide induces neurodegeneration and apoptotic cell death in transgenic mice, Nat Genet, vol.9, pp.21-30, 1995. ,
Alzheimer's disease and the aging brain, J Geriatr Psychiatry Neurol, vol.19, pp.125-128, 2006. ,
Cell toxicity and conformational disease, Trends in Cell Biology, vol.15, pp.574-580, 2005. ,
Mechanisms of Hybrid Oligomer Formation in the Pathogenesis of Combined Alzheimer's and Parkinson's Diseases, PLoS One, vol.3, 2008. ,
Interactions of pathological hallmark proteins: tubulin polymerization promoting protein/p25, beta-amyloid, and alpha-synuclein, J Biol Chem, vol.286, pp.34088-34100, 2011. ,
NBA1/MERIT40 and BRE Interaction Is Required for the Integrity of Two Distinct Deubiquitinating Enzyme BRCC36-containing Complexes, J Biol Chem, vol.286, pp.11734-11745, 2011. ,
MERIT40 facilitates BRCA1 localization and DNA damage repair, Genes Dev, vol.23, pp.719-728, 2009. ,
Spinocerebellar ataxia type 3 phenotypically resembling parkinson disease in a black family, Arch Neurol, vol.58, pp.296-299, 2001. ,
Mitochondrial serine protease HTRA2 p.G399S in a kindred with essential tremor and Parkinson disease, Proceedings of the National Academy of Sciences, vol.111, pp.18285-18290, 2014. ,
Regulation of human MAPT gene expression, Molecular Neurodegeneration, vol.10, p.28, 2015. ,
Phosphorylation affects the ability of tau protein to promote microtubule assembly, J Biol Chem, vol.259, pp.5301-5305, 1984. ,
A Tangled Web -Tau and Sporadic Parkinson's, Disease. Front Psychiatry, vol.1, 2010. ,
, Annexes